| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.93e-05 | 188 | 158 | 9 | GO:0005201 | |
| GeneOntologyMolecularFunction | ubiquitin conjugating enzyme binding | 1.82e-04 | 36 | 158 | 4 | GO:0031624 | |
| GeneOntologyCellularComponent | extracellular matrix | FBLN7 INHBE FRAS1 VWF LAMA1 MUC5B ADAMTS5 SMOC2 ZP2 SSPOP F12 SVEP1 TGM4 FBLN2 FBN1 GPC3 FCN2 CD180 MUC2 FBN3 | 1.69e-07 | 656 | 161 | 20 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | FBLN7 INHBE FRAS1 VWF LAMA1 MUC5B ADAMTS5 SMOC2 ZP2 SSPOP F12 SVEP1 TGM4 FBLN2 FBN1 GPC3 FCN2 CD180 MUC2 FBN3 | 1.77e-07 | 658 | 161 | 20 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | INHBE FRAS1 VWF LAMA1 ADAMTS5 SMOC2 ZP2 SSPOP F12 TGM4 FBLN2 FBN1 GPC3 FCN2 MUC2 | 1.56e-05 | 530 | 161 | 15 | GO:0062023 |
| Domain | VWC_out | 1.61e-12 | 19 | 159 | 8 | SM00215 | |
| Domain | VWFC_1 | 1.45e-11 | 36 | 159 | 9 | PS01208 | |
| Domain | VWFC_2 | 2.47e-11 | 38 | 159 | 9 | PS50184 | |
| Domain | VWC | 2.47e-11 | 38 | 159 | 9 | SM00214 | |
| Domain | VWF_dom | 6.56e-11 | 42 | 159 | 9 | IPR001007 | |
| Domain | Growth_fac_rcpt_ | FRAS1 CRIM1 KRT32 LAMA1 MUC13 SVEP1 JAG2 FBLN2 FBN1 MEGF8 FBN3 NOTCH4 EPHA7 | 8.21e-10 | 156 | 159 | 13 | IPR009030 |
| Domain | EGF_2 | FBLN7 LAMA1 MUC13 SSPOP F12 SVEP1 JAG2 FBLN2 FBN1 MALRD1 MEGF8 ASTN2 FBN3 NOTCH4 EPHA7 | 8.40e-09 | 265 | 159 | 15 | PS01186 |
| Domain | EGF_1 | FBLN7 LAMA1 MUC13 SSPOP F12 SVEP1 JAG2 FBLN2 FBN1 MALRD1 MEGF8 ASTN2 FBN3 NOTCH4 | 3.96e-08 | 255 | 159 | 14 | PS00022 |
| Domain | Unchr_dom_Cys-rich | 5.11e-08 | 13 | 159 | 5 | IPR014853 | |
| Domain | C8 | 5.11e-08 | 13 | 159 | 5 | SM00832 | |
| Domain | TIL_dom | 7.90e-08 | 14 | 159 | 5 | IPR002919 | |
| Domain | VWC | 1.12e-07 | 28 | 159 | 6 | PF00093 | |
| Domain | EGF | FBLN7 FRAS1 LAMA1 MUC13 F12 SVEP1 JAG2 FBLN2 FBN1 MALRD1 MEGF8 FBN3 NOTCH4 | 1.13e-07 | 235 | 159 | 13 | SM00181 |
| Domain | EGF_3 | FBLN7 MUC13 SSPOP F12 SVEP1 JAG2 FBLN2 FBN1 MALRD1 MEGF8 ASTN2 FBN3 NOTCH4 | 1.13e-07 | 235 | 159 | 13 | PS50026 |
| Domain | VWF_type-D | 1.70e-07 | 16 | 159 | 5 | IPR001846 | |
| Domain | VWFD | 1.70e-07 | 16 | 159 | 5 | PS51233 | |
| Domain | VWD | 1.70e-07 | 16 | 159 | 5 | SM00216 | |
| Domain | VWD | 1.70e-07 | 16 | 159 | 5 | PF00094 | |
| Domain | EGF-like_dom | FBLN7 FRAS1 LAMA1 MUC13 F12 SVEP1 JAG2 FBLN2 FBN1 MALRD1 MEGF8 FBN3 NOTCH4 | 2.21e-07 | 249 | 159 | 13 | IPR000742 |
| Domain | EGF-like_CS | FBLN7 LAMA1 MUC13 F12 SVEP1 JAG2 FBLN2 FBN1 MALRD1 MEGF8 FBN3 NOTCH4 EPHA7 | 3.79e-07 | 261 | 159 | 13 | IPR013032 |
| Domain | EGF_CA | 6.99e-07 | 86 | 159 | 8 | PF07645 | |
| Domain | EGF_CA | 1.00e-06 | 122 | 159 | 9 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.15e-06 | 124 | 159 | 9 | IPR001881 | |
| Domain | EGF_Ca-bd_CS | 1.76e-06 | 97 | 159 | 8 | IPR018097 | |
| Domain | EGF_CA | 2.05e-06 | 99 | 159 | 8 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.22e-06 | 100 | 159 | 8 | PS00010 | |
| Domain | C8 | 2.37e-06 | 12 | 159 | 4 | PF08742 | |
| Domain | TIL | 2.37e-06 | 12 | 159 | 4 | PF01826 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.44e-06 | 106 | 159 | 8 | IPR000152 | |
| Domain | CTCK_1 | 1.41e-05 | 18 | 159 | 4 | PS01185 | |
| Domain | LDLR_class-A_CS | 2.17e-05 | 40 | 159 | 5 | IPR023415 | |
| Domain | Ldl_recept_a | 3.90e-05 | 45 | 159 | 5 | PF00057 | |
| Domain | - | 4.34e-05 | 46 | 159 | 5 | 4.10.400.10 | |
| Domain | LDLRA_1 | 5.35e-05 | 48 | 159 | 5 | PS01209 | |
| Domain | Cys_knot_C | 5.56e-05 | 25 | 159 | 4 | IPR006207 | |
| Domain | CTCK_2 | 5.56e-05 | 25 | 159 | 4 | PS01225 | |
| Domain | LDrepeatLR_classA_rpt | 5.92e-05 | 49 | 159 | 5 | IPR002172 | |
| Domain | LDLa | 5.92e-05 | 49 | 159 | 5 | SM00192 | |
| Domain | LDLRA_2 | 5.92e-05 | 49 | 159 | 5 | PS50068 | |
| Domain | hEGF | 8.83e-05 | 28 | 159 | 4 | PF12661 | |
| Domain | Ephrin_rec_like | 9.50e-05 | 11 | 159 | 3 | PF07699 | |
| Domain | EGF | 1.03e-04 | 126 | 159 | 7 | PF00008 | |
| Domain | IBR | 2.06e-04 | 14 | 159 | 3 | PF01485 | |
| Domain | IBR | 2.06e-04 | 14 | 159 | 3 | SM00647 | |
| Domain | FBN | 2.15e-04 | 3 | 159 | 2 | IPR011398 | |
| Domain | IBR_dom | 2.56e-04 | 15 | 159 | 3 | IPR002867 | |
| Domain | CT | 8.28e-04 | 22 | 159 | 3 | SM00041 | |
| Domain | WxxW_domain | 1.06e-03 | 6 | 159 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 1.06e-03 | 6 | 159 | 2 | PF13330 | |
| Domain | Ephrin_rec_like | 1.21e-03 | 25 | 159 | 3 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 1.21e-03 | 25 | 159 | 3 | IPR011641 | |
| Domain | cEGF | 1.36e-03 | 26 | 159 | 3 | PF12662 | |
| Domain | cEGF | 1.36e-03 | 26 | 159 | 3 | IPR026823 | |
| Domain | TB | 1.47e-03 | 7 | 159 | 2 | PF00683 | |
| Domain | Notch_dom | 1.47e-03 | 7 | 159 | 2 | IPR000800 | |
| Domain | Notch | 1.47e-03 | 7 | 159 | 2 | PF00066 | |
| Domain | NL | 1.47e-03 | 7 | 159 | 2 | SM00004 | |
| Domain | DWB | 1.95e-03 | 8 | 159 | 2 | SM00524 | |
| Domain | MH2 | 1.95e-03 | 8 | 159 | 2 | PS51076 | |
| Domain | MH1 | 1.95e-03 | 8 | 159 | 2 | PS51075 | |
| Domain | - | 1.95e-03 | 8 | 159 | 2 | 3.90.290.10 | |
| Domain | - | 1.95e-03 | 8 | 159 | 2 | 3.90.520.10 | |
| Domain | MAD_homology_MH1 | 1.95e-03 | 8 | 159 | 2 | IPR013019 | |
| Domain | Dwarfin | 1.95e-03 | 8 | 159 | 2 | IPR013790 | |
| Domain | EPL1 | 1.95e-03 | 8 | 159 | 2 | PF10513 | |
| Domain | Enhancer_polycomb-like_N | 1.95e-03 | 8 | 159 | 2 | IPR019542 | |
| Domain | MH2 | 1.95e-03 | 8 | 159 | 2 | PF03166 | |
| Domain | SMAD_dom_Dwarfin-type | 1.95e-03 | 8 | 159 | 2 | IPR001132 | |
| Domain | TSP_1 | 2.04e-03 | 63 | 159 | 4 | PF00090 | |
| Domain | TSP1 | 2.29e-03 | 65 | 159 | 4 | SM00209 | |
| Domain | TSP1_rpt | 2.29e-03 | 65 | 159 | 4 | IPR000884 | |
| Domain | TSP1 | 2.29e-03 | 65 | 159 | 4 | PS50092 | |
| Domain | Alpha_adaptinC2 | 2.49e-03 | 9 | 159 | 2 | PF02883 | |
| Domain | TB_dom | 2.49e-03 | 9 | 159 | 2 | IPR017878 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 2.49e-03 | 9 | 159 | 2 | IPR008152 | |
| Domain | Alpha_adaptinC2 | 2.49e-03 | 9 | 159 | 2 | SM00809 | |
| Domain | TB | 2.49e-03 | 9 | 159 | 2 | PS51364 | |
| Domain | E3_UB_ligase_RBR | 3.10e-03 | 10 | 159 | 2 | IPR031127 | |
| Pathway | WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM | 7.76e-06 | 60 | 112 | 6 | M40048 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.61e-05 | 68 | 112 | 6 | M27303 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FRAS1 TBKBP1 MAEA ADGRB2 SIAH2 HUWE1 PRAG1 BABAM2 ADCY9 TYK2 JAG2 KANSL1 EPOP MEGF8 PLEKHM2 CDK13 MTMR3 DIP2C NLRC5 IRS2 SNX11 | 7.25e-08 | 1105 | 165 | 21 | 35748872 |
| Pubmed | 1.02e-07 | 118 | 165 | 8 | 21078624 | ||
| Pubmed | Congenital semilunar valvulogenesis defect in mice deficient in phospholipase C epsilon. | 1.04e-06 | 5 | 165 | 3 | 15743817 | |
| Pubmed | 1.48e-06 | 41 | 165 | 5 | 22675208 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TBKBP1 EPB41L4B MAEA ENC1 HUWE1 KLKP1 SMOC2 SSPOP BABAM2 ITFG1 TYK2 JAG2 ATXN1 CDK13 HPN LRRC1 DIP2C NLRC5 ASTN2 PRKN HSD11B2 CPNE7 | 2.40e-06 | 1489 | 165 | 22 | 28611215 |
| Pubmed | Erk and MAPK signaling is essential for intestinal development through Wnt pathway modulation. | 2.95e-06 | 47 | 165 | 5 | 32747435 | |
| Pubmed | 4.03e-06 | 23 | 165 | 4 | 18787044 | ||
| Pubmed | PAPPA2 VWF SIAH2 HUWE1 SVEP1 MTMR11 KANSL1 AP1B1 CDK13 BRD1 SMAD1 VCPIP1 SMAD9 | 5.46e-06 | 591 | 165 | 13 | 15231748 | |
| Pubmed | 7.87e-06 | 27 | 165 | 4 | 35894043 | ||
| Pubmed | Divergent vascular mechanisms downstream of Sry establish the arterial system in the XY gonad. | 8.63e-06 | 9 | 165 | 3 | 11944948 | |
| Pubmed | Transcriptome analysis of mouse and human sinoatrial node cells reveals a conserved genetic program. | 1.58e-05 | 32 | 165 | 4 | 30936179 | |
| Pubmed | 2.03e-05 | 34 | 165 | 4 | 21311046 | ||
| Pubmed | 2.24e-05 | 12 | 165 | 3 | 17460146 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 9886271 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 25482639 | ||
| Pubmed | Fibrillin-1 and fibulin-2 interact and are colocalized in some tissues. | 2.24e-05 | 2 | 165 | 2 | 8702639 | |
| Pubmed | Regulation of human MutYH DNA glycosylase by the E3 ubiquitin ligase mule. | 2.24e-05 | 2 | 165 | 2 | 24443563 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 24333487 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 9407109 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 15221638 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 23666012 | ||
| Pubmed | [Interleukin-1beta induces MUC2/MUC5B gene expression in human nasal epithelial cells]. | 2.24e-05 | 2 | 165 | 2 | 20873538 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 7897216 | ||
| Pubmed | FRAS1 TSPOAP1 FHIP2A SNX19 KANSL1 MEGF8 PLEKHM2 MTMR3 PLCE1 VCPIP1 | 2.70e-05 | 407 | 165 | 10 | 12693553 | |
| Pubmed | Regional regulation of Filiform tongue papillae development by Ikkα/Irf6. | 2.90e-05 | 13 | 165 | 3 | 27302476 | |
| Pubmed | 3.91e-05 | 40 | 165 | 4 | 27068110 | ||
| Pubmed | Sprouty1 haploinsufficiency prevents renal agenesis in a model of Fraser syndrome. | 4.58e-05 | 15 | 165 | 3 | 23064016 | |
| Pubmed | 5.61e-05 | 16 | 165 | 3 | 19733164 | ||
| Pubmed | Id2 Determines Intestinal Identity through Repression of the Foregut Transcription Factor Irx5. | 5.72e-05 | 44 | 165 | 4 | 29463648 | |
| Pubmed | Non-canonical cyclic AMP SMAD1/5/8 signalling in human granulosa cells. | 6.69e-05 | 3 | 165 | 2 | 30953749 | |
| Pubmed | The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2. | 6.69e-05 | 3 | 165 | 2 | 8550573 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 21381028 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 24023003 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 31127639 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 30898865 | ||
| Pubmed | Fibulin-2 binds to the short arms of laminin-5 and laminin-1 via conserved amino acid sequences. | 6.69e-05 | 3 | 165 | 2 | 9006922 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 19718741 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 28099917 | ||
| Pubmed | Molecular basis of histone H3K36me3 recognition by the PWWP domain of Brpf1. | 6.69e-05 | 3 | 165 | 2 | 20400950 | |
| Pubmed | MADR1, a MAD-related protein that functions in BMP2 signaling pathways. | 6.69e-05 | 3 | 165 | 2 | 8653785 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 20519437 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 27848974 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 10934193 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 22897816 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 19208651 | ||
| Pubmed | Siah proteins induce the epidermal growth factor-dependent degradation of phospholipase Cepsilon. | 6.69e-05 | 3 | 165 | 2 | 17998205 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 8.12e-05 | 18 | 165 | 3 | 18834073 | |
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 8.12e-05 | 18 | 165 | 3 | 35503090 | |
| Pubmed | 9.45e-05 | 153 | 165 | 6 | 25037231 | ||
| Pubmed | LMO4 functions as a negative regulator of sensory organ formation in the mammalian cochlea. | 9.61e-05 | 19 | 165 | 3 | 25057208 | |
| Pubmed | 1.13e-04 | 20 | 165 | 3 | 28655168 | ||
| Pubmed | 1.13e-04 | 20 | 165 | 3 | 19922873 | ||
| Pubmed | 1.13e-04 | 99 | 165 | 5 | 19730683 | ||
| Pubmed | Ureteric morphogenesis requires Fgfr1 and Fgfr2/Frs2α signaling in the metanephric mesenchyme. | 1.31e-04 | 21 | 165 | 3 | 22282599 | |
| Pubmed | 1.31e-04 | 21 | 165 | 3 | 33372189 | ||
| Pubmed | A crucial role of a high mobility group protein HMGA2 in cardiogenesis. | 1.33e-04 | 4 | 165 | 2 | 18425117 | |
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 23993924 | ||
| Pubmed | Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion. | 1.33e-04 | 4 | 165 | 2 | 24258712 | |
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 1.33e-04 | 4 | 165 | 2 | 25034023 | |
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 25638393 | ||
| Pubmed | Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast. | 1.33e-04 | 4 | 165 | 2 | 22269464 | |
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 22691042 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 23703922 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 22452883 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 19933990 | ||
| Pubmed | SIAH2 antagonizes TYK2-STAT3 signaling in lung carcinoma cells. | 1.33e-04 | 4 | 165 | 2 | 24833526 | |
| Pubmed | Characterization of new bone morphogenetic protein (Bmp)-2 regulatory alleles. | 1.33e-04 | 4 | 165 | 2 | 28401685 | |
| Pubmed | Regulation of Sprouty2 stability by mammalian Seven-in-Absentia homolog 2. | 1.33e-04 | 4 | 165 | 2 | 16888801 | |
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 23807779 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 15610515 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 34719843 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 26677226 | ||
| Pubmed | Exchange of associated factors directs a switch in HBO1 acetyltransferase histone tail specificity. | 1.33e-04 | 4 | 165 | 2 | 24065767 | |
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 17471237 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 14984930 | ||
| Pubmed | Lack of evidence that fibrillin1 regulates bone morphogenetic protein 4 activity in kidney or lung. | 1.33e-04 | 4 | 165 | 2 | 36825302 | |
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 17967875 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 1.33e-04 | 4 | 165 | 2 | 29869461 | |
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 21596555 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 37735247 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 25536014 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 19244313 | ||
| Pubmed | A meta-analysis of two genome-wide association studies identifies 3 new loci for alcohol dependence. | 1.33e-04 | 4 | 165 | 2 | 21703634 | |
| Pubmed | Signal transduction of bone morphogenetic protein receptors. | 1.33e-04 | 4 | 165 | 2 | 14687659 | |
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 12676567 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 25755279 | ||
| Pubmed | FGFR2 signaling enhances the SHH-BMP4 signaling axis in early ureter development. | 1.38e-04 | 55 | 165 | 4 | 35020897 | |
| Pubmed | 1.51e-04 | 22 | 165 | 3 | 22366192 | ||
| Pubmed | 1.53e-04 | 167 | 165 | 6 | 22159717 | ||
| Pubmed | 1.63e-04 | 107 | 165 | 5 | 11347906 | ||
| Pubmed | SIAH2 SSPOP BABAM2 JAG2 FBLN2 ZBTB32 MEGF8 SACS ATXN1 USP54 RTL8C | 1.66e-04 | 608 | 165 | 11 | 16713569 | |
| Pubmed | 1.73e-04 | 23 | 165 | 3 | 29981310 | ||
| Pubmed | Msx genes define a population of mural cell precursors required for head blood vessel maturation. | 1.73e-04 | 23 | 165 | 3 | 21693521 | |
| Pubmed | Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions. | 1.85e-04 | 110 | 165 | 5 | 37219487 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.92e-04 | 248 | 165 | 7 | 24006456 | |
| Pubmed | 2.22e-04 | 5 | 165 | 2 | 27188281 | ||
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 2.22e-04 | 5 | 165 | 2 | 11062147 | |
| Pubmed | 2.22e-04 | 5 | 165 | 2 | 20547088 | ||
| Pubmed | Ski represses bone morphogenic protein signaling in Xenopus and mammalian cells. | 2.22e-04 | 5 | 165 | 2 | 11121043 | |
| Pubmed | 2.22e-04 | 5 | 165 | 2 | 12507512 | ||
| Interaction | ATXN7 interactions | 2.43e-06 | 109 | 159 | 8 | int:ATXN7 | |
| Cytoband | 2p23.2 | 1.25e-05 | 13 | 164 | 3 | 2p23.2 | |
| GeneFamily | CD molecules|Mucins | 2.55e-04 | 21 | 108 | 3 | 648 | |
| GeneFamily | SMAD family | 9.67e-04 | 8 | 108 | 2 | 750 | |
| GeneFamily | Fibulins | 9.67e-04 | 8 | 108 | 2 | 556 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 3.53e-03 | 15 | 108 | 2 | 903 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF134 ZNF786 ZNF490 ZNF469 ZBTB32 ZNF665 ZNF648 ZNF333 ZBTB18 ZNF564 ZNF646 | 3.75e-03 | 718 | 108 | 11 | 28 |
| GeneFamily | Exonucleases | 4.02e-03 | 16 | 108 | 2 | 544 | |
| GeneFamily | OTU domain containing | 4.53e-03 | 17 | 108 | 2 | 669 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 4.80e-03 | 57 | 108 | 3 | 1179 | |
| GeneFamily | LIM domain containing | 5.29e-03 | 59 | 108 | 3 | 1218 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 5.66e-03 | 19 | 108 | 2 | 832 | |
| GeneFamily | Proteases, serine | 6.35e-03 | 63 | 108 | 3 | 738 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | FBLN7 FRAS1 VWF CRIM1 LAMA1 KCP SMOC2 ZP2 SSPOP SVEP1 FBLN2 FBN1 PXDNL FBN3 | 2.44e-11 | 196 | 163 | 14 | M3008 |
| Coexpression | NABA_MATRISOME | PAPPA2 FBLN7 INHBE FRAS1 TMPRSS15 VWF CRIM1 LAMA1 KCP MUC5B ADAMTS5 MUC13 SMOC2 ZP2 SSPOP F12 SVEP1 TGM4 FBLN2 FBN1 GPC3 MEGF8 PXDNL FCN2 MUC2 FBN3 | 1.11e-09 | 1026 | 163 | 26 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | FBLN7 FRAS1 VWF CRIM1 LAMA1 KCP SMOC2 ZP2 SSPOP SVEP1 FBLN2 FBN1 PXDNL FBN3 | 2.11e-09 | 275 | 163 | 14 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | FBLN7 FRAS1 VWF CRIM1 LAMA1 KCP SMOC2 ZP2 SSPOP SVEP1 FBLN2 FBN1 | 2.95e-09 | 191 | 163 | 12 | MM17059 |
| Coexpression | NABA_MATRISOME | PAPPA2 FBLN7 INHBE FRAS1 TMPRSS15 VWF CRIM1 LAMA1 KCP MUC5B ADAMTS5 MUC13 SMOC2 MFRP ZP2 SSPOP F12 SVEP1 TGM4 FBLN2 FBN1 GPC3 MEGF8 FCN2 MUC2 | 3.73e-09 | 1008 | 163 | 25 | MM17056 |
| Coexpression | NABA_CORE_MATRISOME | FBLN7 FRAS1 VWF CRIM1 LAMA1 KCP SMOC2 ZP2 SSPOP SVEP1 FBLN2 FBN1 | 1.37e-07 | 270 | 163 | 12 | MM17057 |
| Coexpression | DESCARTES_FETAL_PANCREAS_VASCULAR_ENDOTHELIAL_CELLS | 3.22e-06 | 65 | 163 | 6 | M40266 | |
| Coexpression | JONES_OVARY_PERICYTE | 1.28e-05 | 172 | 163 | 8 | M48351 | |
| Coexpression | JONES_OVARY_NK_CELL | 2.00e-05 | 89 | 163 | 6 | M48353 | |
| Coexpression | AIZARANI_LIVER_C10_MVECS_1 | 4.99e-05 | 269 | 163 | 9 | M39114 | |
| Coexpression | BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP | 5.52e-05 | 211 | 163 | 8 | M2230 | |
| Coexpression | JONES_OVARY_ENDOTHELIAL | 7.19e-05 | 162 | 163 | 7 | M48350 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 9.34e-05 | 117 | 163 | 6 | M39300 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | PAPPA2 ENC1 LAMA1 ITGA8 ADAMTS5 SMOC2 SVEP1 FBLN2 FBN1 GPC3 HSD11B2 CDC25C UTY BICC1 PLCE1 VCPIP1 EPHA7 | 5.19e-05 | 768 | 156 | 17 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 6.16e-05 | 182 | 156 | 8 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | PAPPA2 ENC1 LAMA1 ITGA8 SMOC2 FBLN2 FBN1 GPC3 HSD11B2 BICC1 EPHA7 | 8.21e-05 | 364 | 156 | 11 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 | TREX1 TBKBP1 SPNS2 ENC1 ADGRB2 KCP SIAH2 SMOC2 PRSS36 SVEP1 FBLN2 MTMR11 FBN1 GPC3 WTIP PRKN PRR14L RNF180 FHL3 BICC1 PLCE1 SMAD9 | 9.54e-05 | 1228 | 156 | 22 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | PAPPA2 LAMA1 ITGA8 ADAMTS5 SMOC2 SVEP1 FBN1 GPC3 HSD11B2 BICC1 | 1.02e-04 | 310 | 156 | 10 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | VWF EPB41L4B ENC1 ADGRB2 KCP SMOC2 RNF217 SVEP1 FBLN2 FBN1 GPC3 MEGF8 LRRC1 PRR14L CHST2 CD180 RNF180 BICC1 PLCE1 EPHA7 SMAD9 | 1.04e-04 | 1148 | 156 | 21 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_2500_k-means-cluster#1 | FBLN7 FAM110D ENC1 ITGA8 SNRK ITPRID2 ADAMTS5 CD320 ADGB MTMR11 SACS EXOC3L1 NOSTRIN RNF180 EPHA7 | 1.34e-04 | 672 | 156 | 15 | JC_iEC_2500_K1 |
| ToppCell | droplet-Bladder-Unstain-18m-Endothelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FBLN7 VWF TBKBP1 SPNS2 FAM110D ITGA8 C16orf89 C11orf96 NOTCH4 CPNE7 | 3.05e-09 | 195 | 164 | 10 | fbfe4a8ae9775764108b45920eec92003b24fb2e |
| ToppCell | droplet-Bladder-Unstain-18m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FBLN7 VWF TBKBP1 SPNS2 FAM110D ITGA8 C16orf89 C11orf96 NOTCH4 CPNE7 | 3.05e-09 | 195 | 164 | 10 | 2a6056172c41c46acfe0242be22269ef1d07921e |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | SPRY1 VWF CRIM1 SPNS2 FAM110D JAG2 LRRC1 NOSTRIN NOTCH4 SMAD9 | 3.89e-09 | 200 | 164 | 10 | 27507c4b41d45c7cc50e4993169c0302be22ee34 |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Endothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | SPRY1 VWF CRIM1 SPNS2 FAM110D JAG2 LRRC1 NOSTRIN NOTCH4 SMAD9 | 3.89e-09 | 200 | 164 | 10 | b65fb8d378abd91cdabf5faac5f4b90d527f8c44 |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SPRY1 VWF CRIM1 SPNS2 FAM110D JAG2 LRRC1 NOSTRIN NOTCH4 SMAD9 | 3.89e-09 | 200 | 164 | 10 | 2cb6e35add34b9dc564ebcf5d3cbc761325ca9f4 |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.06e-08 | 177 | 164 | 9 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.06e-08 | 177 | 164 | 9 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAM110D ENC1 SNRK ADAMTS5 CRACR2B C16orf89 EXOC3L1 CHST2 NOSTRIN | 3.47e-08 | 188 | 164 | 9 | 51c6796a9488c056a10d048082015342c2e037f9 |
| ToppCell | droplet-Kidney-KIDNEY-1m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAM110D ENC1 SNRK ADAMTS5 CRACR2B C16orf89 EXOC3L1 CHST2 NOSTRIN | 3.47e-08 | 188 | 164 | 9 | b651024d58ed1bcfe0d80b21755f8bf709eda81f |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | VWF SPNS2 FAM110D CRACR2B C16orf89 FBLN2 PDLIM3 EXOC3L1 NOTCH4 | 3.64e-08 | 189 | 164 | 9 | 2e43428f1ef9683c6f8c9897d46aa7d34bf9047f |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | VWF SPNS2 FAM110D LAMA1 CRACR2B C16orf89 RIN1 PDLIM3 C11orf96 | 3.98e-08 | 191 | 164 | 9 | 9fc674a58f20b47255e4457d5195c8cff17b0414 |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | VWF SPNS2 FAM110D LAMA1 CRACR2B C16orf89 RIN1 PDLIM3 C11orf96 | 3.98e-08 | 191 | 164 | 9 | c379a499dabf3c9ed80f47adbb2d949821c5b053 |
| ToppCell | droplet-Fat-Mat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | VWF CRIM1 SPNS2 FAM110D SNRK CRACR2B C16orf89 PDLIM3 C11orf96 | 4.35e-08 | 193 | 164 | 9 | 54024a373e42e1c0bcc327dc084564b83b63a9d4 |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | VWF CRIM1 SPNS2 FAM110D SNRK CRACR2B C16orf89 PDLIM3 C11orf96 | 4.35e-08 | 193 | 164 | 9 | 81d908594d2983ba7e7c1ec25afdde4315d9690e |
| ToppCell | droplet-Bladder-Unstain-18m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FBLN7 VWF SPNS2 FAM110D ITGA8 C16orf89 C11orf96 NOTCH4 CPNE7 | 4.55e-08 | 194 | 164 | 9 | 9d7cbbcf995274019ca10be0562f114513ec197a |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | VWF CRIM1 SPNS2 FAM110D SNRK CRACR2B C16orf89 PDLIM3 C11orf96 | 4.55e-08 | 194 | 164 | 9 | 74d0eaa76f6d9af14110dfe5b4bf9751b99ff6e3 |
| ToppCell | distal-Endothelial-Bronchial_Vessel_1-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.19e-08 | 197 | 164 | 9 | 0d1afd1ad7489c071db08b3dfff598423097d7e0 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.91e-08 | 200 | 164 | 9 | ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833 | |
| ToppCell | medial-Endothelial-Vein-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.91e-08 | 200 | 164 | 9 | 3f689029f5bc7db0af50a405f1e252aeec529077 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 5.91e-08 | 200 | 164 | 9 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | medial-Endothelial-Vein|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.91e-08 | 200 | 164 | 9 | 1163e5f6dfb304c94bf8885629350454f4b6bee8 | |
| ToppCell | medial-2-Endothelial-Vein|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.91e-08 | 200 | 164 | 9 | 49da4e3ff10262a492c2cf566a7f2e35e418bfda | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.13e-07 | 168 | 164 | 8 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_RSAD2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.33e-07 | 170 | 164 | 8 | 63dfbc4746717132dc81b6bac868c7498fc96283 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.66e-07 | 173 | 164 | 8 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.78e-07 | 174 | 164 | 8 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.04e-07 | 176 | 164 | 8 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-07 | 178 | 164 | 8 | 4df6218b20c2f076c22346d23260964cc0d73e65 | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.31e-07 | 178 | 164 | 8 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.76e-07 | 181 | 164 | 8 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.92e-07 | 182 | 164 | 8 | d0e3663f7d39f22a3ebd7fde56ab3504773598f4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-07 | 182 | 164 | 8 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-07 | 184 | 164 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-07 | 184 | 164 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-07 | 184 | 164 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.44e-07 | 185 | 164 | 8 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.62e-07 | 186 | 164 | 8 | b80aaeebc03a318052076d2f02c123f5ddc5e73a | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.62e-07 | 186 | 164 | 8 | 8a8ed1502542d4895cba3fd5d534256206578716 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.81e-07 | 187 | 164 | 8 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | Endothelial-Endothelial-E|Endothelial / shred on cell class and cell subclass (v4) | 5.01e-07 | 188 | 164 | 8 | 2777eb7689b271c199021fe7d9db88ccebff14de | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.22e-07 | 189 | 164 | 8 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.22e-07 | 189 | 164 | 8 | fccadf8efbef17b7f12291b069c71060a71b04e2 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.22e-07 | 189 | 164 | 8 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.43e-07 | 190 | 164 | 8 | 06bfb62b94b0faf467ef93d5bc5d08924c770098 | |
| ToppCell | 15-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 5.43e-07 | 190 | 164 | 8 | b47472dc9fe6ed99c2365203a3d8a59879e74a70 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.65e-07 | 191 | 164 | 8 | b51e0f5d1b93f526160c904e9091313a5364f3a7 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.65e-07 | 191 | 164 | 8 | cd497abed9e00e4e0becd9dbc036c6e7a60ae791 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-07 | 193 | 164 | 8 | 59b8186d0221fba06a16157e9d148399ed801f38 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-07 | 193 | 164 | 8 | f95b95c58a6edb8a03dd15ae166f47f9f33d8bd6 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-07 | 193 | 164 | 8 | dc92680b4bb9fc26430c92e03adb839c8c3b3b98 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-07 | 193 | 164 | 8 | 03678162648bd5b1d65a5450b60c8863edbf95c7 | |
| ToppCell | IPF-Endothelial-VE_Venous|IPF / Disease state, Lineage and Cell class | 6.11e-07 | 193 | 164 | 8 | 29a655fa80feaabe846c90a28363b037e22d24ae | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-07 | 193 | 164 | 8 | 85faf6c5ce4769615a4eca036e2ba307e176bb52 | |
| ToppCell | IPF-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 6.11e-07 | 193 | 164 | 8 | ef66a46e7ab44fcc4005a23416e6da478a4cce37 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-07 | 193 | 164 | 8 | 110a7d2ba7d066c2be38be98b643b76c520dd980 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 6.36e-07 | 194 | 164 | 8 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 6.61e-07 | 195 | 164 | 8 | 120296531bbc8080dcabacbd64733cc1dc34603a | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 6.61e-07 | 195 | 164 | 8 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.61e-07 | 195 | 164 | 8 | f65053811074a7f2ff0368f3a63b88e2a08da1a0 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|IPF / Disease state, Lineage and Cell class | 6.61e-07 | 195 | 164 | 8 | 2c3ad3cb79f11119ac69c413a938d21199145040 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.61e-07 | 195 | 164 | 8 | 752a100297c26732e12bbbf3ab27a2bd4f5ea06d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.87e-07 | 196 | 164 | 8 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | ASK454-Endothelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.87e-07 | 196 | 164 | 8 | 14dd6956ef420b660be0baf52a66960e57d75d16 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.87e-07 | 196 | 164 | 8 | 481d79bdaec069ad2746a28d39eeee8d3edf7305 | |
| ToppCell | ASK454-Endothelial-Endothelium|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.87e-07 | 196 | 164 | 8 | 2b777a2026b56839112fd179f2db482c49f4594a | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 7.14e-07 | 197 | 164 | 8 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.14e-07 | 197 | 164 | 8 | ab5d3ebc73bd7cfc64381d14b92878b370205186 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.14e-07 | 197 | 164 | 8 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.14e-07 | 197 | 164 | 8 | 131bc6ef55f467cc802db68daf7e7d757ea64fc6 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.14e-07 | 197 | 164 | 8 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | distal-Endothelial-Bronchial_Vessel_1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.14e-07 | 197 | 164 | 8 | f45a93b5ad80a16b760acbaa6467648ffc05a0d3 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 7.14e-07 | 197 | 164 | 8 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.14e-07 | 197 | 164 | 8 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.14e-07 | 197 | 164 | 8 | 9b3d6fe76dd7d61a286a28d9466b5f2fece048e1 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.14e-07 | 197 | 164 | 8 | c29ed0e706999d4c2b93e6e3bf46c42aeceb4813 | |
| ToppCell | 390C-Endothelial_cells|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.14e-07 | 197 | 164 | 8 | aa381acea0f7882d39435a6f713386bf0588b5f8 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.41e-07 | 198 | 164 | 8 | eac26ed95b4a4343a5dfe1fbecef9374e5947884 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.41e-07 | 198 | 164 | 8 | ff8a9adc1302a4679ccdfe9ef95ef53e4c7a5391 | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 7.41e-07 | 198 | 164 | 8 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.41e-07 | 198 | 164 | 8 | 5b86dc00acf8ac2ede008f5d79c09996485bf250 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.41e-07 | 198 | 164 | 8 | 09e452742aed9f48bf1ffc35c6b06a296bcfe076 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.41e-07 | 198 | 164 | 8 | 37d6557833877fc2ff51fbeb589e3eb832dbef5f | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.41e-07 | 198 | 164 | 8 | a8c21f4db6730d0aa05b61fbe72bf9f7571a9015 | |
| ToppCell | (6)_Endothelial-A_(Artery)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.41e-07 | 198 | 164 | 8 | 44f8cd5afa3685dcc8bfea0b15af5e8817e12e2e | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.41e-07 | 198 | 164 | 8 | 8b68fc887e5ad0a59ea4d93dfd1edda67030f142 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.41e-07 | 198 | 164 | 8 | 13203249e5743ba2699871c184d141207e550a86 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating3_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.41e-07 | 198 | 164 | 8 | 5fe186d46c47ea1ca450cf67e8eb01c2c3f7f83c | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.41e-07 | 198 | 164 | 8 | 4739b2e4ab141c66772e61686b45614a1839483e | |
| ToppCell | ASK452-Mesenchymal-Fibroblast|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.70e-07 | 199 | 164 | 8 | 4d0bf2a4bd97e5a3bfe4570a201cc21bb9c4c1f6 | |
| ToppCell | ASK452-Mesenchymal|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.70e-07 | 199 | 164 | 8 | 93e85e3731a9ece9aee3eb82c5dfdad331ee62d6 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 7.70e-07 | 199 | 164 | 8 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.70e-07 | 199 | 164 | 8 | 0602e2b2aa56d106da63bd342a38bef437b4d496 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.70e-07 | 199 | 164 | 8 | 463ba77dc4c85eebb343f29a42c7ac889b0497c9 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 7.70e-07 | 199 | 164 | 8 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | 367C-Endothelial_cells-Endothelial-A_(Artery)|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.70e-07 | 199 | 164 | 8 | 29ed081bd5204a32068b420f2244f3704891547b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.70e-07 | 199 | 164 | 8 | 212e89d097753790061310373a1fafba773488b6 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-A_(Artery)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.70e-07 | 199 | 164 | 8 | c2d85f80037f209a4a329790f475d9f98f590262 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.70e-07 | 199 | 164 | 8 | 14b676aa289c0578a37be32cec3ea285c79d97cc | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.00e-07 | 200 | 164 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.00e-07 | 200 | 164 | 8 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| Disease | pulse pressure measurement | PAPPA2 CRIM1 MAEA PCDHA12 SMOC2 ZNF831 SSPOP SNX19 SVEP1 FBN1 MALRD1 KANSL1 MEGF8 ATXN1 PLEKHM2 PXDNL C11orf96 LRRC1 SNX11 BRD1 FHL3 BICC1 PLCE1 | 2.15e-06 | 1392 | 161 | 23 | EFO_0005763 |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 8.75e-06 | 8 | 161 | 3 | DOID:4783 (biomarker_via_orthology) | |
| Disease | O-methylcatechol sulfate measurement | 2.96e-05 | 2 | 161 | 2 | EFO_0022102 | |
| Disease | COVID-19 symptoms measurement | 3.92e-05 | 35 | 161 | 4 | EFO_0600019 | |
| Disease | X-24513 measurement | 8.84e-05 | 3 | 161 | 2 | EFO_0022133 | |
| Disease | connective tissue disease (implicated_via_orthology) | 8.84e-05 | 3 | 161 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | X-21658 measurement | 1.76e-04 | 4 | 161 | 2 | EFO_0022121 | |
| Disease | lactotransferrin measurement | 1.76e-04 | 4 | 161 | 2 | EFO_0020526 | |
| Disease | hypertension, pregnancy-induced | 2.93e-04 | 5 | 161 | 2 | MONDO_0024664 | |
| Disease | central corneal thickness | 3.11e-04 | 309 | 161 | 8 | EFO_0005213 | |
| Disease | cortical surface area measurement | SPRY1 SMOC2 SVEP1 TG JAG2 ZNF469 MTMR11 FBN1 KANSL1 EPOP ASTN2 BRD1 CD180 CDC25C ZBTB18 FBN3 PLCE1 EPHA7 | 4.14e-04 | 1345 | 161 | 18 | EFO_0010736 |
| Disease | beta-hydroxybutyric acid measurement | 4.37e-04 | 6 | 161 | 2 | EFO_0010465 | |
| Disease | 2,3-dihydroxy-5-methylthio-4-pentenoate (DMTPA) measurement | 4.37e-04 | 6 | 161 | 2 | EFO_0800111 | |
| Disease | solute carrier family 22 member 16 measurement | 4.37e-04 | 6 | 161 | 2 | EFO_0802079 | |
| Disease | IGF-like family receptor 1 measurement | 4.37e-04 | 6 | 161 | 2 | EFO_0801687 | |
| Disease | cysteine-rich with EGF-like domain protein 1 measurement | 7.04e-04 | 32 | 161 | 3 | EFO_0021870 | |
| Disease | cesarean section, anxiety | 8.11e-04 | 8 | 161 | 2 | EFO_0005230, EFO_0009636 | |
| Disease | corneal resistance factor | 8.69e-04 | 451 | 161 | 9 | EFO_0010067 | |
| Disease | schizophrenia (is_implicated_in) | 8.90e-04 | 78 | 161 | 4 | DOID:5419 (is_implicated_in) | |
| Disease | Idiopathic pulmonary hypertension | 1.04e-03 | 9 | 161 | 2 | C0152171 | |
| Disease | propionylcarnitine measurement | 1.04e-03 | 9 | 161 | 2 | EFO_0020942 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 1.08e-03 | 37 | 161 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | cortical thickness | FBLN7 CRIM1 LAMA1 SMOC2 TG JAG2 ZNF469 FBN1 ZBTB32 MALRD1 KANSL1 MTMR3 ASTN2 PLCE1 EPHA7 | 1.18e-03 | 1113 | 161 | 15 | EFO_0004840 |
| Disease | Degenerative Diseases, Central Nervous System | 1.26e-03 | 39 | 161 | 3 | C0270715 | |
| Disease | Neurodegenerative Disorders | 1.26e-03 | 39 | 161 | 3 | C0524851 | |
| Disease | Degenerative Diseases, Spinal Cord | 1.26e-03 | 39 | 161 | 3 | C0751733 | |
| Disease | response to anticoagulant | 1.46e-03 | 41 | 161 | 3 | GO_0061476 | |
| Disease | microphthalmia (implicated_via_orthology) | 1.88e-03 | 12 | 161 | 2 | DOID:10629 (implicated_via_orthology) | |
| Disease | thyroid stimulating hormone measurement | 2.05e-03 | 323 | 161 | 7 | EFO_0004748 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 2.22e-03 | 13 | 161 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | Skin Abnormalities | 2.22e-03 | 13 | 161 | 2 | C0037268 | |
| Disease | 2-oxo-hept-3-ene-1,7-dioate hydratase activity | 2.58e-03 | 14 | 161 | 2 | C1150929 | |
| Disease | retinal drusen | 2.74e-03 | 51 | 161 | 3 | EFO_1001155 | |
| Disease | lymphocyte count | INHBE FRAS1 ENC1 SPPL3 ZNF831 ADCY9 TYK2 ZNF469 FBN1 MTHFD1 CDK13 NLRC5 PRKN CHST2 NOSTRIN FUT7 PLCE1 | 2.75e-03 | 1464 | 161 | 17 | EFO_0004587 |
| Disease | body surface area | PAPPA2 CRIM1 EPB41L4B SMOC2 ADCY9 FBLN2 MTMR11 FBN1 MTMR3 ASTN2 | 2.89e-03 | 643 | 161 | 10 | EFO_0022196 |
| Disease | Inherited oocyte maturation defect | 3.38e-03 | 16 | 161 | 2 | cv:CN238505 | |
| Disease | preeclampsia, hypertension, pregnancy-induced | 3.38e-03 | 16 | 161 | 2 | EFO_0000668, MONDO_0024664 | |
| Disease | Idiopathic pulmonary arterial hypertension | 3.38e-03 | 16 | 161 | 2 | C3203102 | |
| Disease | physical activity measurement, body mass index | 3.58e-03 | 114 | 161 | 4 | EFO_0004340, EFO_0008002 | |
| Disease | lymphocyte percentage of leukocytes | TSPOAP1 TSPAN32 ZNF831 ADCY9 TYK2 KANSL1 ATXN1 CDK13 NLRC5 NOTCH4 | 3.67e-03 | 665 | 161 | 10 | EFO_0007993 |
| Disease | Familial primary pulmonary hypertension | 3.81e-03 | 17 | 161 | 2 | C0340543 | |
| Disease | Withdrawal Symptoms | 3.95e-03 | 58 | 161 | 3 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 3.95e-03 | 58 | 161 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 3.95e-03 | 58 | 161 | 3 | C0038587 | |
| Disease | aspartate aminotransferase measurement | FBLN7 SPPL3 THSD7B PRAG1 HARS2 AP1B1 ATXN1 NLRC5 ASTN2 NOSTRIN NOTCH4 PLCE1 | 4.12e-03 | 904 | 161 | 12 | EFO_0004736 |
| Disease | ischemia (biomarker_via_orthology) | 4.27e-03 | 18 | 161 | 2 | DOID:326 (biomarker_via_orthology) | |
| Disease | Lipoidosis | 4.76e-03 | 19 | 161 | 2 | C0023794 | |
| Disease | longevity | 4.80e-03 | 284 | 161 | 6 | EFO_0004300 | |
| Disease | Cocaine Abuse | 5.25e-03 | 127 | 161 | 4 | C0009171 | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 5.27e-03 | 20 | 161 | 2 | DOID:2921 (biomarker_via_orthology) | |
| Disease | Colorectal Carcinoma | 5.34e-03 | 702 | 161 | 10 | C0009402 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CLSRPTAPKSGACLA | 46 | A8MZ25 | |
| KCPPNASGSASRRCL | 556 | O60241 | |
| KASGPLPSKCVAIDC | 101 | Q8WTP8 | |
| ALAPASCLPSGSCAR | 726 | Q86VI1 | |
| TPSAKRCILCNFLPG | 21 | P59051 | |
| SPLCDSSFNAPKCGR | 861 | O95696 | |
| QTLCKTPPRSLSAGA | 1236 | O94986 | |
| PCGLSDLCRSLMTKP | 176 | Q6UX73 | |
| QKDFRAPTTCLGPTC | 6 | Q96QU6 | |
| LPCLSRDSPCNSFAI | 1091 | Q8N7X0 | |
| KGCPLSQRPSAFKQC | 911 | Q9UNA0 | |
| PPGLSLDFLKCCKRN | 256 | P28335 | |
| TALLCQELGLPCSSP | 481 | A5YM72 | |
| PGNPSCTDLELSLKC | 916 | Q10567 | |
| CPERTSQLFDLPCSK | 661 | P54253 | |
| LNSPGAIELRTCCSP | 116 | P80365 | |
| TCANPPSLRGVKLSD | 606 | Q99467 | |
| TNLCLNGRCLPTPSS | 416 | Q75N90 | |
| ASCPAGLACPSLDIL | 431 | Q9H694 | |
| AQLELISRICGSPCP | 921 | Q14004 | |
| TCHLCRRPGKEQLSP | 986 | O75129 | |
| PASCPDVSSCRGSLR | 5631 | Q9HC84 | |
| ALEPGLASCLSPKCL | 1481 | O95153 | |
| LGSVLPPCRSVCQEA | 531 | Q9BY79 | |
| LACPEPRASQNCLSK | 16 | Q53RD9 | |
| SHCTACSPPKALRQG | 621 | Q86XX4 | |
| SPDCPVCSRSLNKLA | 311 | Q7L5Y9 | |
| QPSSCLASRCLPGEQ | 36 | A4FU01 | |
| DLQVCLPKGPTCCSR | 61 | P51654 | |
| SAQCPLGQRCLEKAP | 921 | Q9Y219 | |
| PTKFQCRTSGLCVPL | 56 | Q9NPF0 | |
| LQASLKSCPRPASVC | 11 | Q14532 | |
| ASLCPCQSVKFRPGL | 11 | Q96PT3 | |
| PGSSPCTDALTCIKA | 186 | P98073 | |
| CPSCGGSKLAPQAER | 26 | P58166 | |
| SLSEPCRPGFSCINT | 816 | P98095 | |
| RTATLCPKTCPGNLV | 286 | Q02817 | |
| DCTPSPLCQLIKDSL | 4686 | Q02817 | |
| NGRPLCASCLVPTVA | 206 | Q11130 | |
| PCRLLSSPEACNQSG | 1876 | Q7Z7M0 | |
| STIRPGCDVNPSCAL | 621 | Q7Z3B3 | |
| KSPHILCSQPNACSR | 36 | Q107X0 | |
| ASPDCITILCKPNGQ | 231 | Q8N9Z9 | |
| NCCEEKRNPSSSTLP | 391 | Q9UJY4 | |
| CPCGNRSISLDRLPN | 816 | Q7L590 | |
| CKRLLPLATTGDGNC | 196 | Q8TE49 | |
| LTKDPRLACVLGTPC | 126 | Q6ZWI9 | |
| ADVSPINCSLCLKPD | 56 | A6NEC2 | |
| LRDCNSLPGVLGTCK | 106 | Q15375 | |
| LLSLCTPNSLPSGCE | 951 | Q7Z6Z7 | |
| CGSRSADNLSCPSPL | 1051 | P28290 | |
| GSQAPLIAPLCCAAA | 11 | P53708 | |
| PCCSRPKVAALTAGT | 11 | P05981 | |
| SEPTCQENLPRCGAL | 421 | Q9BTT6 | |
| LPTFLAGLASCTCRP | 561 | Q86WI3 | |
| CSPAQLLCSTPNGLD | 121 | P30307 | |
| ENCTIALPECGKAPR | 316 | Q5K4E3 | |
| CCRSRKKGPISQPLD | 286 | Q3MJ16 | |
| LFTDEALKPCPRCQS | 631 | Q4G163 | |
| SLAATPPAAKCSSCR | 346 | Q9Y4H2 | |
| FQDCSPLLSPERKCT | 1251 | Q5VYJ5 | |
| PASCLLSCNQRSLPA | 406 | Q86YG4 | |
| IHRPCGKQDSCPSLL | 1386 | Q9BXP8 | |
| LSGCTARRPLPNCSN | 706 | A1KZ92 | |
| LFAPKCSSCKRPIVG | 216 | Q13643 | |
| AASAPSSLLDQPCLC | 391 | Q969S8 | |
| KSGCTSLTPGPNCDR | 41 | Q9NXR7 | |
| RKPCRGTQEFSPLCL | 26 | A6NHQ4 | |
| QPCLTGPRTCKDLLD | 96 | Q15485 | |
| PRKCAPGTCQNLDGS | 1981 | P35555 | |
| LPAPCASKVELRLSC | 16 | Q9UBL6 | |
| KALTTARLPGPTCCC | 366 | Q8N4Y2 | |
| PPACGELSNCTLTGK | 466 | Q9NZV1 | |
| KGLRQEVICPCASSP | 641 | Q9Y2E4 | |
| NLKTCPSCGITFAPK | 626 | O60503 | |
| IPSPRKEFSACAIGC | 326 | O14682 | |
| LAPAPRSGECLCLTD | 31 | Q9Y3B6 | |
| PEPAAAKCLTQSTCL | 291 | Q5W0V3 | |
| SLPRSACLCSRNSAP | 56 | O15255 | |
| LKCKVCLRPFGDPSN | 601 | Q9H4Q3 | |
| SSPDTNCHIGKLPCR | 3106 | Q9NZJ4 | |
| DFRDSKLQCCPGPTS | 831 | Q9H329 | |
| GPCPDSAARFCLNLT | 126 | Q8N4B5 | |
| ARGDLNDCFIPCTPK | 136 | P11586 | |
| RKPACAQSLLPCSVA | 351 | Q68DL7 | |
| CLKKPEDSSAPRCLG | 396 | Q9Y661 | |
| CALEPSGCTSLPSKA | 481 | Q8NAC3 | |
| DTRCPKPASQIGCSA | 196 | Q9BQA1 | |
| TRSPCALPLAECKEG | 911 | Q13615 | |
| VVCGPCSEKRFLLPS | 181 | Q9H8W4 | |
| ESCTSPCLLGAPRKA | 1481 | Q5THK1 | |
| GRSSCQPRKPALDLS | 911 | A6NGG8 | |
| RCAPGKPTLVCSSAV | 731 | Q9UN75 | |
| CLRTLAKDNPSSTPC | 456 | Q86T96 | |
| PAPGAAQLSSRLCKA | 431 | Q8IVI9 | |
| LLSSGAAAQPLPDCC | 26 | O43612 | |
| CQLKRDQPSPCLSSA | 551 | Q8IWE5 | |
| CLPSGAARPSETTLC | 486 | P00748 | |
| ICPSSTEVLKACRNP | 836 | O14607 | |
| PSATPVDCSLCGKKR | 221 | Q5MJ70 | |
| LSSPLCCDFGRPKEG | 226 | Q9Y5W9 | |
| CQALCMRLPEASGPS | 101 | Q13671 | |
| LSQLLRPPCASCTGA | 16 | P49590 | |
| VPISSCRCGLPSANA | 4721 | A2VEC9 | |
| SLPCVAGCPNSLIKE | 286 | O60260 | |
| ATARSPQPCSLLGTK | 1146 | Q4G0N8 | |
| SCAPGSDPRSNLCAL | 511 | P02788 | |
| RDLGTPECQSSLPCL | 561 | Q9P212 | |
| PLPCKLQVTERGSCC | 941 | Q6ZWJ8 | |
| TFALRADNPLGCSPC | 1136 | P25391 | |
| QKLSCCPTCRGALTP | 106 | O43255 | |
| ETCNSPPCGAKDSLI | 351 | Q8IVW8 | |
| ELGATVCTPQRPLCS | 281 | Q9UIF7 | |
| RITPGSKAAAANLCP | 31 | Q53GG5 | |
| IRKSEATPSPGACLQ | 336 | Q2NL68 | |
| FCCGPSPLTAIRKGD | 361 | P49221 | |
| SCCLLSPDANVKAAP | 81 | Q8NHX4 | |
| LGRIDSSTKPCPQCK | 336 | Q8TC41 | |
| PGKNISCRCDPSEIN | 1051 | Q2Y0W8 | |
| GLKNFPCTPESLCDV | 231 | O95149 | |
| SAIGCASRCLPNSKL | 6 | Q8TBB0 | |
| QTSAKCEKISCGPPA | 3406 | Q4LDE5 | |
| GPLCNLPLSSCQKAA | 876 | Q99466 | |
| RNPKEGLLCASSPAS | 746 | Q9NRH2 | |
| AGKRALCPTCSLPLS | 146 | Q8TAY7 | |
| ITUQCKENLPSLCSU | 316 | P49908 | |
| ERALSCPGQPSKCVT | 56 | O15198 | |
| LEKALSCPGQPSNCV | 51 | Q15797 | |
| LQSPSRAVDCALCPN | 321 | P55201 | |
| GAATNKVVCSSPLCP | 251 | Q9Y4C5 | |
| GKDPCCSLRPLSNSV | 36 | Q7Z7L8 | |
| SLDISCKCVNTDLPP | 46 | Q9H7R5 | |
| CPECGKAFISLPSVR | 171 | Q8TBZ8 | |
| SPSSALRLCCAGPSQ | 91 | Q96NJ1 | |
| NLETPTGLKPCDCSV | 146 | Q9ULM2 | |
| KLECRKTTCNPCPLG | 2616 | P04275 | |
| GLACDCKSDLQRPNP | 341 | Q9H3R2 | |
| SLDCAGSPQKPLCAS | 41 | Q9H3U7 | |
| ACGRQPQEPSLLRCS | 241 | Q96QS1 | |
| LTRPCSPQNKISFGC | 121 | Q8TCT6 | |
| SKPAADVNVPTCSLC | 401 | Q99592 | |
| GLCALAGSEKPSPCQ | 16 | Q03403 | |
| AGSEKPSPCQCSRLS | 21 | Q03403 | |
| RPGEATSAQPFLCCL | 871 | O15015 | |
| PGRNKAKSTCSCPDL | 51 | O43847 | |
| KCKCGECTAPRTLPS | 186 | O43609 | |
| SQCPKNAPCSLAILS | 86 | A0A0A0MS06 | |
| DRRILSGSCPDPKCQ | 41 | Q96JH7 | |
| ILDCCPGSPVAKAAS | 256 | Q86YV5 | |
| CPSRPSCLEKDLTND | 476 | Q92543 | |
| LTTSPCDPKEALAGC | 2171 | Q96JG9 | |
| PCKPSCVSQLGQRAE | 46 | Q96JL9 | |
| AQCTPCGKRSLPVDS | 296 | Q8N393 | |
| PCPDCGKAFVRSSDL | 336 | Q5T619 | |
| NCSLLPADPASVLCS | 141 | Q05066 | |
| ASCARPILPAQGCET | 351 | A6NIX2 | |
| TGEKPFSCSLCPQRS | 396 | Q9Y2Y4 | |
| DSILKQLCSVPCPGD | 1356 | Q9C0I4 | |
| CCLSRSVPLPAEQKA | 1186 | Q5JPB2 | |
| SGLCSNDCPRKITPF | 446 | Q8TB96 | |
| SDIRSCPLCQLGFPV | 581 | A7MCY6 | |
| KLSLCVAPGKACSPA | 66 | Q9NSU2 | |
| AKCLPNSPCSLEIQA | 86 | A0A087WV62 | |
| SKLPTCPGSCEEAKL | 916 | P01266 | |
| SALICNRLSPDSPLC | 616 | Q05996 | |
| KAGLPAQTALPCDIC | 41 | P52741 | |
| SLRRCCLPQPGETSN | 546 | P29597 | |
| GSRCDNSSCSKLPPQ | 1001 | Q70EL1 | |
| SATVAAKGHPCLRCP | 61 | Q147X3 | |
| CGKSASPLKVLCTPE | 1231 | P54296 |